GCA
NTUS

Greenwood Capital Associates’s Natus Medical Inc NTUS Stock Holding History

Greenwood Capital Associates’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-7,768
Closed -$264K – 211
2018
Q4 		$264K Buy
7,768
+1,184
+18% +$38.5K 0.07% 142
2018
Q3 		$235K Buy
6,584
+10
+0.2% +$353 0.05% 167
2018
Q2 		$227K Sell
6,574
-8
-0.1% -$280 0.05% 177
2018
Q1 		$221K Buy
6,582
+848
+15% +$26.8K 0.05% 175
2017
Q4 		$219K Buy
+5,734
New +$229K 0.05% 196

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Greenwood Capital Associates's NTUS Position: Q1 2019 in Review

Greenwood Capital Associates sold out of Natus Medical Inc (NTUS) in Q1 2019, closing a stake of 7,768 shares — an estimated $264K sold.

Greenwood Capital Associates first reported a position in NTUS in Q4 2017 and held it in 5 quarters. The position peaked at $264K in Q4 2018. 168 funds tracked by Wall St. Rank hold NTUS as of Q1 2019.

  • Greenwood Capital Associates reported no remaining Natus Medical Inc position as of Q1 2019 after selling out during the quarter.
  • Greenwood Capital Associates sold 7,768 Natus Medical Inc shares in Q1 2019, an estimated $264K.
  • Greenwood Capital Associates first reported a position in Natus Medical Inc in Q4 2017 and held it in 5 quarters.
  • Greenwood Capital Associates's Natus Medical Inc position peaked at $264K in Q4 2018.
  • 168 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2019.

Based on Greenwood Capital Associates's 13F filing for Q1 2019, filed 3 May 2019.